Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conference highlight.

Journal of the International Association of Physicians in AIDS Care - 1 Aug 1995

Abstract excerpt

The Sardinia Conference included a presentation on the virological results of a randomized, double-blind study that assessed the antiviral activity and tolerability of the HIV-proteinase inhibitor saquinavir (SQV), combined with zidovudine (ZDV), in totally antiretroviral naive patients. Results show SQV to have high antiviral activity in vivo, clearly additive to that of ZDV, with results comparable in magnitude...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Saquinavir
Share to Zidovudine
Share to Randomized Controlled Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Drug Resistance, Microbial

Share to HIV Protease Inhibitors

Share to Isoquinolines

Share to Quinolines

Source

Identifiers

PMID: 11362749

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conference highlight.PMID 11362749Read ↗

Rational approaches to resistance: using saquinavir.Semantic proximity Read ↗

FDA triple header. Food and Drug Administration.Semantic proximity Read ↗

Protease inhibitors: drug resistance and cross resistance overview.Semantic proximity Read ↗

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.Semantic proximity Read ↗

The medical merry-go-round: drugs for 1998 are new but not novel.Semantic proximity Read ↗

Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir.Semantic proximity Read ↗

Roche investigators say Invirase does not cause cross-resistance to other protease inhibitors.Semantic proximity Read ↗

A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?Semantic proximity Read ↗

Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.Semantic proximity Read ↗

Ritonavir, saquinavir combination--& warning.Semantic proximity Read ↗

Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudine.Semantic proximity Read ↗

Evaluation of a didanosin-containing regimen including genotypic resistance testing: an open-label, multicenter study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.